DHG Pharmaceutical JSCSTC:DHG -0.11%78 Interest Coverage is 36.31 as of Mar. 2026, which is 0% below its 10-year median of 36.37. GuruFocus rates STC:DHG with a GF Score™ of 78/100 and a GF Value™ of ₫113,390.11 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 685 Drug Manufacturers companies, DHG Pharmaceutical JSC ranks better than 67.15% on this metric.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's
Operating Income
by its Interest Expense. DHG Pharmaceutical JSC's
Operating Income
for the
three
months ended in Mar. 2026 was ₫329,240 Mil. DHG Pharmaceutical JSC's Interest Expense for the
three
months ended in Mar. 2026 was ₫-9,068 Mil.
DHG Pharmaceutical JSC's interest coverage for the quarter that ended in Mar. 2026 was 36.31.
The higher the ratio, the stronger the company's financial strength is.
The historical rank and industry rank for DHG Pharmaceutical JSC's Interest Coverage or its related term are showing as below:
STC:DHG'
s Interest Coverage Range Over the Past 10 Years
Min: 24.61 Med: 36.37 Max: 85.6
Current: 35.41
STC:DHG's Interest Coverage is ranked better than 67.15% of 685
companies
in the Drug Manufacturers industry
Industry Median: 12.78
vs STC:DHG: 35.41
Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.
Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .
DHG Pharmaceutical JSC Interest Coverage Related Terms
DHG Pharmaceutical JSC Interest Coverage Historical Data
* Premium members only.
The historical data trend for DHG Pharmaceutical JSC's Interest Coverage can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.
For the Drug Manufacturers - Specialty & Generic subindustry, DHG Pharmaceutical JSC's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
DHG Pharmaceutical JSC Interest Coverage vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, DHG Pharmaceutical JSC's Interest Coverage distribution charts can be found below:
* The bar in red indicates where DHG Pharmaceutical JSC's Interest Coverage falls into.
Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
DHG Pharmaceutical JSC (STC:DHG) has a Interest Coverage of 36.31 as of Mar. 2026. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on DHG Pharmaceutical JSC and its competitors. This is near median its historical median of 36.37. Over the past decade, DHG Pharmaceutical JSC's Interest Coverage has ranged from 24.61 to 85.60. According to the industry distribution chart, DHG Pharmaceutical JSC ranks #225 out of 685 companies in the Drug Manufacturers industry, placing it in the top 32.8%.
Is DHG Pharmaceutical JSC's Interest Coverage too high?
DHG Pharmaceutical JSC's current Interest Coverage of 36.31 is near median its 10-year median of 36.37. Over the past 10 years, this metric has ranged from a low of 24.61 to a high of 85.60. The Drug Manufacturers industry median Interest Coverage is 12.78. DHG Pharmaceutical JSC's value of 36.31 is 184.1% above this industry median. Based on the distribution chart, DHG Pharmaceutical JSC ranks #225 out of 685 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, DHG Pharmaceutical JSC has a GF Score™ of 78/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DHG Pharmaceutical JSC's Interest Coverage compare to ZTS?
According to the Drug Manufacturers industry distribution chart, DHG Pharmaceutical JSC ranks #225 out of 685 companies for Interest Coverage. This puts DHG Pharmaceutical JSC in the upper half of its industry. The industry median Interest Coverage is 12.78. DHG Pharmaceutical JSC's value of 36.31 is 184.1% above this benchmark. Historically, DHG Pharmaceutical JSC's own Interest Coverage has ranged from 24.61 to 85.60 over the past decade. While the company's 10-year median is 36.37 vs. the industry median of 12.78, DHG Pharmaceutical JSC has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Coverage for a Drug Manufacturers company?
The median Interest Coverage among Drug Manufacturers companies is 12.78, based on 685 companies in the industry. Companies in the top quartile (top 25%) have a Interest Coverage significantly above this median, while those in the bottom quartile fall well below. However, Interest Coverage should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. DHG Pharmaceutical JSC's current Interest Coverage of 36.31 is 184.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Coverage mean?
A high Interest Coverage can signal that a stock is expensive relative to its fundamentals. Interest Coverage measures a company's capability to pay interest expenses on its debt. View historical data on DHG Pharmaceutical JSC and its competitors. For the Drug Manufacturers industry, the median Interest Coverage is 12.78 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DHG Pharmaceutical JSC's current Interest Coverage is 36.31, which is near median its own 10-year median of 36.37. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DHG Pharmaceutical JSC stock overvalued right now?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC (STC:DHG) is currently considered Modestly Undervalued. The stock's GF Value™ is ₫113,390.11, compared to a current price of ₫93,800.00 — trading 17.3% below its estimated fair value. The current Interest Coverage is 36.31, which is near median its 10-year median of 36.37 and 184.1% above the Drug Manufacturers industry median of 12.78. DHG Pharmaceutical JSC's overall GF Score™ is 78/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Coverage calculated?
Interest Coverage is calculated from a company's financial statements. For DHG Pharmaceutical JSC (STC:DHG), the current Interest Coverage is 36.31 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is DHG Pharmaceutical JSC (STC:DHG) Overvalued in 2026?
Based on GuruFocus' analysis, DHG Pharmaceutical JSC stock appears to be undervalued.
The current stock price of ₫93,800.00 is trading 17.3% below its estimated GF Value™ of ₫113,390.11.
GuruFocus considers DHG Pharmaceutical JSC to be Modestly Undervalued.
Key valuation signals for STC:DHG:
Interest Coverage: 36.31 (near median its 10-year median of 36.37)
GF Value™: ₫113,390.11 vs. price of ₫93,800.00 (17.3% below fair value)
Industry Position: 184.1% above the Drug Manufacturers median (#225 of 685)
No single metric tells the full story. See the STC:DHG stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
DHG Pharmaceutical JSC produces and trades in pharmaceutical products. It provides various pharmaceutical products in the areas of antibiotics, antifungals, and antiparasitics; analgesics and antipyretics; ear-nose-throat, cough, and asthma; ophthalmic and nervous system; muscular and osteoarticular; digestive; hepatic; cardiovascular and diabetic; vitamins and minerals; and dermal and beauty care.
78GF Score
Get the complete analysis for STC:DHG
Interest Coverage is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STC:DHG has been successfully added to your 
